Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 681-686

  Malyszko, Jolanta ^a   Malyszko, Jacek S ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Kidney function; Kidney transplantation; NGAL

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PREDNISONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DONOR SELECTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ALLOGRAFT; KIDNEY FAILURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIPOCALINS; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 70350166789     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01034.x     Document Type: Article

References (32)

1. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004, 30:33.
2. Al Suwaidi J, Reddan DN, Williams K. GUSTO-IIb, GUSTO-III, PURSUIT. Global Use of Strategies to Open Occluded Coronary Arteries. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy; PARAGON-A Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002, 106:974.
3. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425.
4. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45:17.
5. Mishra J, Dent C, Tarabishi R. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231.
6. Mori K, Lee HT, Rapoport D. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115:610.
7. Ding H, He Y, Li K. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007, 123:227.
8. Rubinstein T, Pitashny M, Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis. Autoimmun Rev 2008, 7:229.
9. Bolignano D, Coppolino G, Campo S. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol 2007, 27:373.
10. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 2008, 13:153.
11. National Kidney Foundation K/DOQI: Clinical Practice Guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1.
12. Mitsnefes MM, Kathman TS, Mishra J. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007, 22:101.
13. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Ren Fail 2008, 30:1.
14. Schmitt-Ott KM, Mori K, Li JY. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007, 18:407.
15. Schmidt-Ott KM, Mori K, Kalandadze A. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006, 15:442.
16. Grigoryev DN, Liu M, Hassoun HT. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008, 19:547.
17. Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron 2002, 90:133.
18. Hemdahl AL, Gabrielsen A, Zhu C. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006, 26:136.
19. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients. Transplantation 1996, 62:828.
20. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Cholesterol and Recurrent Events (CARE) Trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005, 68:237.
21. Panichi V, Migliori M, De Pietro S. C-reactive protein in patients with chronic renal diseases. Ren Fail 2001, 23:551.
22. Mishra J, Ma Q, Prada A. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14:2534.
23. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004, 24:307.
24. Parikh CR, Jani A, Mishra J. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006, 6:1639.
25. Mishra J, Ma Q, Kelly C. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006, 21:856.
26. Kusaka M, Kuroyanagi Y, Mori T. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant 2008, 17:129.
27. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993, 91:2144.
28. Ruggenenti P, Perico N, Mosconi L. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993, 43:706.
29. Schaub S, Mayr M, Hönger G. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation 2007, 84:104.
30. Nickolas TL, O'Rourke MJ, Yang J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008, 148:810.
31. Dent CL, Ma Q, Dastrala S. Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007, 11:R127.
32. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007, 71:967.